Due to health issues, this site is no longer maintained and will be shut down shortly.

ANVS Annovis Bio, Inc.

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimerís disease (AD), Parkinsonís disease (PD) and Alzheimerís in Down Syndrome (AD-DS).

$18.59  -0.21 (-1.12%)
As of 03/27/2023 12:40:37 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/29/2002
Outstanding shares:  8,163,923
Average volume:  36,134
Market cap:   $150,787,658
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy